Factor V Leiden ICD-10-CM Codes
Explore the ICD-10-CM codes pertinent to the Factor V Leiden genetic predisposition. A comprehensive coding guide for hereditary thrombophilia disorders.
Fact Checked by Ericka Pingol.
What ICD-10 Codes are Used for Factor V Leiden
Factor V Leiden is a mutation of one of the clotting factors in the blood, leading to an increased risk of developing abnormal blood clots. The ICD-10-CM classification system provides specific codes for this genetic condition.
Here's the key ICD-10-CM code for Factor V Leiden:
D68.59: Other primary thrombophilia
Clinical Description: This code encompasses inherited thrombophilia conditions, including the Factor V Leiden mutation.
Which Factor V Leiden ICD Codes are Billable:
- D68.59: Yes
Clinical Information
- Factor V Leiden is the most prevalent inherited coagulation disorder in people of European ancestry.
- This mutation causes a change in clotting factor V, making it less susceptible to being inactivated, leading to hypercoagulability.
- Those with Factor V Leiden mutation have a heightened risk for venous thromboembolism, including deep vein thrombosis and pulmonary embolism.
- While many carriers of the mutation never develop abnormal clots, they are at an increased risk, especially when combined with other clotting risk factors.
- Treatment or preventive measures might involve anticoagulant medications, particularly if the individual has had previous clotting events.
Synonyms Include
- Activated protein C resistance
- Factor V mutation
- Genetic predisposition to clotting
- Hereditary thrombophilia
.png)
Commonly asked questions
The Factor V Leiden ICD-10-CM code should be utilized in medical records when diagnosing, treating, or documenting a patient known to have this particular genetic predisposition to increased clotting.
Factor V Leiden is usually diagnosed via a blood test, which may be prompted due to a personal or familial history of blood clots, or when other indicators of heightened clotting risk are evident.
A diagnosis code for Factor V Leiden offers a standardized manner to indicate that a patient possesses this specific genetic mutation increasing their risk of abnormal blood clots. This standardized coding aids in clinical care, research, and administrative functions like billing and insurance claims processing.
